Evidence map›Paper›PMID 26880990›Full record

ArticleStem cells international2016

Corrigendum to "Particle Radiation-Induced Nontargeted Effects in Bone-Marrow-Derived Endothelial Progenitor Cells".

Sharath P Sasi, Daniel Park, Sujatha Muralidharan, Justin Wage, Albert Kiladjian, Jillian Onufrak, Heiko Enderling, Xinhua Yan, David A Goukassian

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cells international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sharath P SasiCardiovascular Research Center, GeneSys Research Institute, Boston, MA 02135, USA.
Daniel ParkCardiovascular Research Center, GeneSys Research Institute, Boston, MA 02135, USA.
Sujatha MuralidharanWhitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
Justin WageCardiovascular Research Center, GeneSys Research Institute, Boston, MA 02135, USA.
Albert KiladjianCardiovascular Research Center, GeneSys Research Institute, Boston, MA 02135, USA.
Jillian OnufrakCardiovascular Research Center, GeneSys Research Institute, Boston, MA 02135, USA.
Heiko EnderlingDepartment of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Xinhua YanCardiovascular Research Center, GeneSys Research Institute, Boston, MA 02135, USA; Tufts University School of Medicine, Boston, MA 02118, USA.
David A GoukassianCardiovascular Research Center, GeneSys Research Institute, Boston, MA 02135, USA; Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA; Tufts University School of Medicine, Boston, MA 02118, USA.
Genesys (United States) · USBoston University · USMoffitt Cancer Center · US

Funding

Neuregulin1 Alleviation of the "On-Target" Cardiotoxicity Caused by Inhibition ofR21HL106098 · NHLBI · GENESYS RESEARCH INSTITUTE, INC. · PI YAN, XINHUA · 2012 to 2013
$450k
NHLBI NIH HHS R21 HL106098
6 · The paper itself

Abstract

[This corrects the article DOI: 10.1155/2015/496512.].

Identifiers

PMID26880990
PMCPMC4736558
OpenAlexW2228935096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.